Aims and Scope

Asian Journal of Social Pharmacy (AJSP) is peer-reviewed quarterly English journal jointly hosted by Herbal Font Pharmaceutical Limited and Shenyang Pharmaceutical University. AJSP is dedicated to providing researchers, pharmacists, administrators,and educators working within the field of pharmacy worldwide with a platform of communication in the advancement and development in social pharmacy.The journal welcomes original contributions in pharmacy-related research including policies,regulations and laws, administration, monitoring,inspection, surveillance, utilization, formulary analysis, drug manufacturing, drug marketing,drug R&D, pharmacy practice, clinical pharmacy,pharmacoeconomics, and modernization of traditional Chinese medicine. To expedite the dissemination of findings from latest research, the journal receives rapid research report. Rapid research reports can be published within 3 months on submission, which does not preclude publication of full length reports of the research work in other journals.

General Rules

● For each submission, detailed contact information for the first author including name,professional qualifications, major research area,telephone numbers and E-mail should be provided.

● Original research papers should have no more than 6 authors who should be from no more than 3 institutions. Review articles should have no more than 3 authors who should be from no more than 2 institutions. Full details of affiliations and addresses should be provided. In principle, adding and changing authors will not be allowed once a manuscript is submitted.

● Authors should keep their own copy of submitted manuscripts as manuscripts not accepted for publication will not be retuned. Authors will be notif i ed once a decision has been made by the editorial office. Authors should send their revised manuscript back to the journal in due course if revision is required. Otherwise authors will be deemed to forfeit publication.

Manuscript Preparation

a. Title

The title of a manuscript should be meaningful and concise (recommended word count: ≤ 20 words).Abbreviations, acronyms, or codes not well-known by the public should be avoided in the title.

b. Abstract and Keywords

A structured, one-paragraph abstract including the headings of objective(s), method(s), result(s) and conclusion(s) is required. The abstract should be a complete summary of the main text. Tables, figures,diagrams (such as those showing chemical structures),and non-standard symbols should be avoided in the abstract. The abstracts should be followed by 3 to 8 keywords.

c. Headings and Subheadings

It is recommended that the headings and subheadings of the main text not exceed 3 levels.The headings and subheadings within the same level should use similar structures and tones.

d. Introduction

Theoretical foundations, research strategies,current status of related research area, etc., should be summarized using 200 to 300 words. Research objectives of the manuscript should also be clearly and accurately stated in this section.

e. Materials and Instruments

Product name, composition, specif i cation, purity,source, manufacturer, and batch number should be clearly indicated for drugs and reagents used in the study. Species, age, weight, quantity, and source should be specified for experiment animals used.Product names and models should be provided for instruments used. Latin names should be given for traditional Chinese herbs when they fi rst appear in the manuscript. Use Italic font whenever appropriate.

f. Methods

Authors can just reference without providing details if the methods they used have been documented in the published literature. New methods or methods modified from existing ones should be specified so that other researchers can replicate.

g. Units of Measurement and Abbreviations

Units of measurement must be international units collected in the Legal Units of Measurement of People's Republic of China, for example, s(second), min (minute), h (hour), d (day), and y(year). Commonly used abbreviations and symbols are acceptable. Examples include ♀(female), ♂(male), t(time), p (pressure), V(volume), 10-6(quantity of rare material), δ =2.5 (chemical shift), iv (intravenous injection), im (muscle inside injection), ip (abdomen injection), sc (subcutaneous injection), icv (brain room injection), ia (artery injection), po (oral), ig (infusing stomach).

h. Tables and Figures

Try not using tables and figures wherever text is sufficient. Tables and figures should be selfexplanatory and the data presented in tables and figures should not be repeated in the text. Titles of tables and fi gures should be in English. All tables and figures should be numbered (with Arabic numerals)in the order of appearance. Each figure should be submitted in 2 copies. One is inserted in the main text where it should appear; the other is on a separate page attached to the manuscript.

i. Presentation of Concentration

If the accurate molecular weight of a component in a mixture is known, the concentration of the component should be given as amount-of-substance concentration cB(the quantity of component B divided by the volume of mixture, i.e. mol/L); if the accurate molecular weight of a component is unknown, the concentration should be given as mass concentration ρB(the weight of component B divided by the volume of mixture, i.e. kg/L). Other forms of acceptable presentation of concentration include mass fraction wB(i.e. the ratio of the mass of compound B to the total mass of the mixture) and volume fraction φB(i.e. the ratio of component volume to the mixture volume).For example, 95% ethanol should be presented as w(C2H5OH)=95% or w(C2H5OH)=0.95, which means 100g ethanol mixture contains 95g ethanol.

j. Fonts

Song Ti and Times New Roman are the recommended fonts for Chinese and English,respectively. Foreign character should be in italics whenever appropriate, for example, p (pressure),V (volume), (x,y) (sign of reference frame), Latin name senior to genus (including genus) in biology(e.g. Valerian officinalis L. var. latifolia Miq.),signs representing optical rotation, configuration,conformation, and position of replacement (e.g.d (dextrorotatory), l (levorotatory), dl (racemate),o-(ortho), p- (para), m- (meta), iso-(ectopia)),compounds containing double bonds (e.g. Z(Zusammen), E (Entegegen)), dimensional structure of chiral compounds (e.g. R (Rectus), S (Sinister)),amino acids, peptide, and glucide (e.g. D (replacement on the right), L (replacement on the left)), position of replacement of chemical element (e.g. N, O, P, S),some statistical symbols (e.g. sample size (n), standard error (s), F test, t test), Latin terms (e.g. in vivo and in vitro), and foreign names of author's aff i liations.

k. Discussion and Conclusion

Results and main fi ndings should be summarized and discussed to obtain creative, enlightening, and practical conclusions. Strength and weakness of the study should be clearly stated and future research directions should be indicated.

l. References

References should be compiled numerically according to the order of citation. The number of references should not exceed 20 for original research papers and 30 for review articles. List all authors if there are 3 or fewer authors for a referenced article and list only the first 3 authors followed by et al. if there are more than 3 authors.

Examples of references

[1] Wu Hongyan, Sun Lihua. Comparison of EQ-5D value sets between UK and Japan and the influences on the results of cost-utility [J].Chinese Health Economics, 2012, 31 (7): 9-11.

[2] Janssen M F, Simon P A, Golicki D, et al.Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study [J]. Quality of Life Research, 2013, 22: 1717-1727.

[3] Zhu Yanbo. The Measure and Evaluate of Quality of Life [M]. Beijing: People's Military Medical Press, 2010: 19.

[4] International Diabetes Federation. IDF diabetes atlas update 2013, 6th edition estimates 2013-2035 [EB/OL]. (2014-03-07)[2015-04-07]. http://www.idf.org/diabetesatlas/data-downloads.

[5] Zhao Yongxin, Wu Yuehui. The people's daily review: why is it slow for innovation drug clinical review [N/OL]. People's Daily, (2015-08-11)[2015-09-16]. http://www.biodiscover.com/news/politics/121109.html.

Additional Information

Additional information can be obtained from the editorial office or you can visit http://www.asianjsp.com.

Manuscript Submission

Manuscripts can be submitted totally on line.

Editorial Off i ce

Asian Journal of Social Pharmacy

Shenyang Pharmaceutical University

No.103, Wenhua Road, Shenyang, 110016

P. R. China.

Tel: 024-23986082

E-mail: tx830127@163.com

Online submission: asianjsp.syphu.edu.cn